ARTICLE | Product Development
Survey says: Companies seek regulatory flexibility as COVID-19 makes clinical disruptions the new norm
A BioCentury/BIO joint survey finds COVID-19 has forced many companies to modify their clinical trials
March 26, 2020 1:57 AM UTC